| Program for Appropriate Technology in Health (PATH) |
Seattle, WA, USA |
| PATH Malaria Vaccine Initiative |
Bethesda, MD, USA |
| Medicines for Malaria Venture |
Geneva, Switzerland |
| International AIDS Vaccine Initiative |
New York, NY, USA |
| International Partnership for Microbiocides |
Silver Spring, MD, USA |
| Aeras Global TB Vaccine Foundation |
Rockville, MD, USA |
| Global Alliance for TB Drug Development |
New York, NY, USA |
| Drugs for Neglected Diseases Initiative |
Geneva, Switzerland, USA |
| Institute for One World Health |
San Francisco, CA, USA |
| Foundation for Innovative New Diagnostics |
Geneva, Switzerland, USA |
| Human Hookworm Vaccine Initiative- Sabin Vaccine Institute |
Washington, D.C., USA |
| Infectious Disease Research Institute |
Seattle, WA, USA |
| Pediatric Dengue Vaccine Initiative |
Seoul, Korea |
| Innovative Vector Control Consortium |
Liverpool, UK |
| UNC Consortium for Parasitic Drug Development |
Chapel Hill, NC, USA |
| International Vaccine Institute |
Seoul, Korea |
| PATH Vaccine Solutions |
Washington, D.C. and Seattle , WA, USA |
| PATH Pneumococcal Vaccine Development Program |
Washington, D.C. and Seattle , WA, USA |
| PATH Influenza Vaccine Development Program |
Washington, D.C. and Seattle , WA, USA |
| PATH Advancing Rotavirus Vaccine Development |
Washington, D.C. and Seattle , WA, USA |
| PATH Enteric Vaccine Initiative |
Washington, D.C. and Seattle , WA, USA |
| PATH Meningitis Vaccine Project |
Washington, D.C. and Seattle , WA, USA |
| WHO-TDR |
Geneva, Switzerland |
